Cholesterol Research Today is a free monthly online journal that collates and summarizes the latest research about Cholesterol, including details on high cholesterol, hdl, ldl, diet, risks.

Volume 2 (2005), Issue 8 (August)

1. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) alters the mRNA expression of critical genes associated with cholesterol metabolism, bile acid biosynthesis, and bile transport in rat liver: a microarray study.
   Toxicol Appl Pharmacol, 207(1): 1-24. [Abstract] [Full-text]
2. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?
   Am J Cardiol, 96(3): 399-404. [Abstract] [Full-text]
3. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.
   Cell Metab, 1(5): 309-22. [Abstract] [Full-text]
4. Insig-mediated degradation of HMG CoA reductase stimulated by lanosterol, an intermediate in the synthesis of cholesterol.
   Cell Metab, 1(3): 179-89. [Abstract] [Full-text]
5. ABCG1 has a critical role in mediating cholesterol efflux to HDL and preventing cellular lipid accumulation.
   Cell Metab, 1(2): 121-31. [Abstract] [Full-text]
6. The sterol-sensing domain of the Niemann-Pick C1 (NPC1) protein regulates trafficking of low density lipoprotein cholesterol.
   J Biol Chem, 280(31): 28581-90. [Abstract] [Full-text]
7. Alzheimer's disease--a dysfunction in cholesterol and lipid metabolism.
   Cell Mol Neurobiol, 25(3): 475-83. [Abstract] [Full-text]
8. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice.
   J Clin Invest, 115(8): 2192-201. [Abstract] [Full-text]
9. Saturated fat-rich diet enhances selective uptake of LDL cholesteryl esters in the arterial wall.
   J Clin Invest, 115(8): 2214-22. [Abstract] [Full-text]
10. PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1.
    J Clin Invest, 115(8): 2244-56. [Abstract] [Full-text]
11. Patients with atherosclerosis may have increased circulating levels of 27-hydroxycholesterol and cholestenoic acid.
    Scand J Clin Lab Invest, 65(5): 365-75. [Abstract] [Full-text]
12. New insights into the genetic regulation of intestinal cholesterol absorption.
    Gastroenterology, 129(2): 718-34. [Abstract] [Full-text]
13. L-folic acid supplementation in healthy postmenopausal women: effect on homocysteine and glycolipid metabolism.
    J Clin Endocrinol Metab, 90(8): 4622-9. [Abstract] [Full-text]
14. Familial massive tendon xanthomatosis with decreased high-density lipoprotein-mediated cholesterol efflux.
    Metabolism, 54(8): 1095-101. [Abstract] [Full-text]
15. The endothelial cholesterol efflux is promoted by the high-density lipoprotein anionic peptide factor.
    Metabolism, 54(8): 1087-94. [Abstract] [Full-text]
16. Low-density lipoprotein apolipoprotein B production differs between laboratory opossums exhibiting high and low lipemic responses to dietary cholesterol and fat.
    Metabolism, 54(8): 1075-81. [Abstract] [Full-text]
17. Influence of apolipoprotein E genotype on the reliability of the Friedewald formula in the estimation of low-density lipoprotein cholesterol concentrations.
    Metabolism, 54(8): 1014-9. [Abstract] [Full-text]
18. Altered hepatic cholesterol metabolism compensates for disruption of phosphatidylcholine transfer protein in mice.
    Am J Physiol Gastrointest Liver Physiol, 289(3): G456-61. [Abstract] [Full-text]
19. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production.
    Am J Physiol Gastrointest Liver Physiol, 289(3): G592-8. [Abstract] [Full-text]
20. Pharmacologic options for aggressive low-density lipoprotein cholesterol lowering: benefits versus risks.
    Am J Cardiol, 96(4): 60E-66E. [Abstract] [Full-text]
21. Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations.
    Am J Cardiol, 96(4): 556-63. [Abstract] [Full-text]
22. Yolk sac cholesteryl ester secretion rates can be manipulated in the Golden Syrian hamster: effect of yolk sac cholesterol concentrations.
    Biochim Biophys Acta, 1735(3): 214-21. [Abstract] [Full-text]
23. Cholic acid as key regulator of cholesterol synthesis, intestinal absorption and hepatic storage in mice.
    Biochim Biophys Acta, 1735(3): 167-75. [Abstract] [Full-text]
24. Isothermal titration calorimetry studies of the binding of the antimicrobial peptide gramicidin S to phospholipid bilayer membranes.
    Biochemistry, 44(33): 11279-85. [Abstract] [Full-text]
25. Ethnic disparities: control of glycemia, blood pressure, and LDL cholesterol among US adults with type 2 diabetes.
    Ann Pharmacother, 39(9): 1489-501. [Abstract] [Full-text]
26. Electron paramagnetic resonance studies of magnetically aligned phospholipid bilayers utilizing a phospholipid spin label: the effect of cholesterol.
    Biochim Biophys Acta, 1714(2): 141-51. [Abstract] [Full-text]
27. Study of the surface morphology of a cholesteryl tethering system for lipidic bilayers.
    Biochim Biophys Acta, 1714(2): 93-102. [Abstract] [Full-text]
28. Serum lipid profile in colorectal cancer patients with and without synchronous distant metastases.
    Oncology, 68(4): 371-4. [Abstract] [Full-text]
29. Lipid efflux in human and mouse macrophagic cells: evidence for differential regulation of phospholipid and cholesterol efflux.
    J Lipid Res, 46(9): 1877-87. [Abstract] [Full-text]
30. Short-term stimulation of lipogenesis by 3,5-L-diiodothyronine in cultured rat hepatocytes.
    Endocrinology, 146(9): 3959-66. [Abstract] [Full-text]
31. N-acyl phosphatidylethanolamines affect the lateral distribution of cholesterol in membranes.
    Biochim Biophys Acta, 1715(1): 49-56. [Abstract] [Full-text]
32. ABCG1 redistributes cell cholesterol to domains removable by high density lipoprotein but not by lipid-depleted apolipoproteins.
    J Biol Chem, 280(34): 30150-7. [Abstract] [Full-text]
33. Identification of a novel selective peroxisome proliferator-activated receptor alpha agonist, 2-methyl-2-(4-{3-[1-(4-methylbenzyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]propyl}phenoxy)propanoic acid (LY518674), that produces marked changes in serum lipids and apolipoprotein A-1 expression.
    Mol Pharmacol, 68(3): 763-8. [Abstract] [Full-text]
34. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol.
    Am J Cardiol, 96(5): 24F-33F. [Abstract] [Full-text]
35. Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions.
    Am J Cardiol, 96(5): 11F-23F. [Abstract] [Full-text]
36. Increased cellular cholesterol efflux in glycogen storage disease type Ia mice: a potential mechanism that protects against premature atherosclerosis.
    FEBS Lett, 579(21): 4713-8. [Abstract] [Full-text]
37. Guilty until proven innocent: the case of NPC1 and cholesterol.
    Trends Biochem Sci, 30(9): 498-505. [Abstract] [Full-text]
38. Red Star Ruby (Sunrise) and blond qualities of Jaffa grapefruits and their influence on plasma lipid levels and plasma antioxidant activity in rats fed with cholesterol-containing and cholesterol-free diets.
    Life Sci, 77(19): 2384-97. [Abstract] [Full-text]
39. Genome scan for quantitative trait loci influencing HDL levels: evidence for multilocus inheritance in familial combined hyperlipidemia.
    Hum Genet, 117(5): 494-505. [Abstract] [Full-text]
40. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides.
    Hum Genet, 117(5): 444-51. [Abstract] [Full-text]

© 2004-2008 Cholesterol Research Today. All Rights Reserved.